Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - Edwards Lifesciences; Medtronic; Boston Scientific Corporation; Abbott</li><li>Consultant Fee/Honoraria/Speaker's Bureau - Edwards Lifesciences; Medtronic; V-Wave; Abbott</li></ul>